Information for Authors - Publication


     Publication Fees
     Licensing Options
     Distribution of Materials Described in Published Papers

We will forward your unedited manuscript to our publisher for posting to the (Articles in Press)section of our web site. Your article should be posted within 2-3 days of receipt of files.

The publisher will forward page proofs to you for your final review within 4-6 weeks. The final version of your paper will be published online once proof corrections have been received.

Our medical illustration staff may redraw or reformat line art and graphs for publication quality, or contact you if higher quality versions are needed. Please be sure to carefully review your figures when you receive your publication proofs.

For a complete list of rights you retain as author, click here.

There is a press embargo for all studies published in CMGH until they are posted online in our Articles in Press section as the paginated author-corrected proof in an "in progress" issue. Studies cannot be publicized as accepted manuscripts or uncorrected proofs. Please see our embargo policy at www.cmghjournal.org/content/embargo for more details.

Manuscripts are copyedited to make them consistent with Journal style. If a particular section in the manuscript is not clear or requires additional information, the copy editor will direct questions to the author. These questions, or "author queries," will appear in the proofs that are sent to the author. Authors are required to return proofs to the publisher within 48 hours. If changes are not returned within 48 hours, the manuscript will move forward in the production process.

Publication Fees
For papers that are accepted for publication, authors will be charged a publication fee. If the corresponding or first author is an AGA member, the fee is $1200. Non-members pay $2000. Cases of hardship will be considered on an individual basis. There are no color, page, or open access charges. Submission fees are presently waived.

Licensing Options
CMGH offers authors the choice of different forms of Creative Commons licenses that will allow others to make use of the published work. Authors must select the type of license at the time of submission. An overview of these licenses is included below. For more detailed information, please go to https://www.elsevier.com/openaccesslicenses.

Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): Allows others to access and download an article and share it with others as long as they credit the author (and do not represent the author as endorsing their work), but they cannot change the article in any way or use it commercially.

Distribution of Materials Described in Published Papers

Authors are expected to make available materials such as cell lines, cDNA clones, DNA constructs, antibodies, biological reagents, unique animals, etc. to any qualified investigator. Prior to the submission of newly cloned genes or nucleic acid sequences, the Journal requires authors to provide an accession number to a publicly accessible, recognized data repository (e.g. GenBank) on the title page of the manuscript.

Transcript profiling (expression microarray) data must be submitted to an appropriate repository (either NCBI's GEO or EBI's ArrayExpress). The data should preferably be MIAME compliant (http://www.mged.org/Workgroups/MIAME/miame.html). The repository URL and the data accession number must be included, both in the body of the manuscript and in the manuscript management system, upon submission. The full dataset must be available to reviewers.

Other large datasets produced using genomics technologies (including but not limited to ChIP on Chip, Genotyping, aCGH and Tilling Arrays) must be deposited in an appropriate public repository. Please include the repository URL and the data accession number, both in the body of the manuscript and the manuscript management system, upon submission. If there is no public repository for the submitted data, it is the author's responsibility to provide permanent publicly accessible links to the raw data and access for the reviewers.

Chemical Compounds: Authors must furnish information about the identity and purity of new chemical compounds. Experimental details and characterization data should be provided in either the main text or as supplemental material. Experimental details should be sufficient to allow other researchers to reproduce the synthesis of the compound.

These guidelines are a means of encouraging the free exchange of scientific information and to promote progress in all areas of investigation.


General Information
     Ethical Standards and Policies
     Article Types
     Contact Information

Submitting a Manuscript
     Submission Guidelines

Manuscript Processing and Review
     Submissions
     Review process
     Decisions



     Accepted Manuscript Information
     Revised Submission Guidelines